{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:52:21Z","timestamp":1778737941497,"version":"3.51.4"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1306900"],"award-info":[{"award-number":["2016YFC1306900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC0905002"],"award-info":[{"award-number":["2016YFC0905002"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573508"],"award-info":[{"award-number":["81573508"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874327"],"award-info":[{"award-number":["81874327"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.brainres.2019.05.023","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T15:06:26Z","timestamp":1558364786000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats"],"prefix":"10.1016","volume":"1719","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7007-1440","authenticated-orcid":false,"given":"Chao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yuan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Ye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2114-7514","authenticated-orcid":false,"given":"Zhao-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.05.023_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1523\/JNEUROSCI.16-01-00019.1996","article-title":"Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics","volume":"16","author":"Akbarian","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.05.023_b0010","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38744","article-title":"Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease","volume":"7","author":"Arnoux","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.brainres.2019.05.023_b0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.brainres.2019.05.023_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pnpbp.2013.11.008","article-title":"Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically","volume":"49","author":"Brown","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0025","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pbb.2005.01.012","article-title":"The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating","volume":"80","author":"Bubenikova","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2019.05.023_b0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2018.01.004","article-title":"Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies","volume":"83","author":"Burghardt","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0035","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.11124\/JBISRIR-2017-003380","article-title":"Metformin and Alzheimer's disease, dementia and cognitive impairment: a systematic review protocol","volume":"15","author":"Campbell","year":"2017","journal-title":"JBI Database System Rev. Implement Rep."},{"key":"10.1016\/j.brainres.2019.05.023_b0040","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1159\/000494573","article-title":"Atypical antipsychotic drug olanzapine deregulates hepatic lipid metabolism and aortic inflammation and aggravates atherosclerosis","volume":"50","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.brainres.2019.05.023_b0045","first-page":"148","article-title":"Molecular mechanisms of psychostimulant addiction","volume":"32","author":"Chen","year":"2009","journal-title":"Chang Gung Med. J."},{"key":"10.1016\/j.brainres.2019.05.023_b0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainres.2017.09.006","article-title":"Chronic atypical antipsychotics, but not haloperidol, increase neurogenesis in the hippocampus of adult mouse","volume":"1676","author":"Chikama","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/mp.2016.214","article-title":"Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3beta kinase: implications for Alzheimer's disease","volume":"22","author":"Chu","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.brainres.2019.05.023_b0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2019.05.023_b0070","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.neuropharm.2011.06.027","article-title":"MK-801 increases the baseline level of anxiety in mice introduced to a spatial memory task without prior habituation","volume":"61","author":"Ennaceur","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.05.023_b0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(96)00024-2","article-title":"Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity","volume":"21","author":"Farber","year":"1996","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0080","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1093\/brain\/awx202","article-title":"Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease","volume":"140","author":"Fitzgerald","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.05.023_b0085","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2174\/1389450110607011399","article-title":"Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders","volume":"7","author":"Gould","year":"2006","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.brainres.2019.05.023_b0090","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.apjtm.2016.05.019","article-title":"Effects of scallop shell extract on scopolamine-induced memory impairment and MK801-induced locomotor activity","volume":"9","author":"Hasegawa","year":"2016","journal-title":"Asian Pac J Trop Med."},{"key":"10.1016\/j.brainres.2019.05.023_b0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/0269881110389214","article-title":"Metformin for obesity and glucose dysregulation in patients with schizophrenia receiving antipsychotic drugs","volume":"25","author":"Hasnain","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.05.023_b0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.biopsycho.2017.07.016","article-title":"Deficient prepulse inhibition of the startle reflex in schizophrenia using a cross-modal paradigm","volume":"128","author":"Hass","year":"2017","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.brainres.2019.05.023_b0110","doi-asserted-by":"crossref","first-page":"7208429","DOI":"10.1155\/2016\/7208429","article-title":"The effect of diabetes medication on cognitive function: evidence from the PATH through life study","volume":"2016","author":"Herath","year":"2016","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.brainres.2019.05.023_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and dopamine in schizophrenia: an update for the 21st century","volume":"29","author":"Howes","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.05.023_b0120","article-title":"Metformin and berberine prevent olanzapine-induced weight gain in rats","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.05.023_b0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2017.09.014","article-title":"Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice","volume":"126","author":"Jeon","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.05.023_b0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/YCO.0b013e3280ba4975","article-title":"Cognitive heterogeneity in schizophrenia","volume":"20","author":"Joyce","year":"2007","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2019.05.023_b0145","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.05.023_b0150","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s11064-016-1917-x","article-title":"Sub-chronic antipsychotic drug administration reverses the expression of Neuregulin 1 and ErbB4 in a cultured MK801-induced mouse primary hippocampal neuron or a neurodevelopmental schizophrenia model","volume":"41","author":"Li","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fphar.2018.00379","article-title":"The Wnt signaling pathway effector TCF7L2 mediates olanzapine-induced weight gain and insulin resistance","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2019.05.023_b0160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neubiorev.2010.08.001","article-title":"GSK-3beta activity and hyperdopamine-dependent behaviors","volume":"35","author":"Li","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2019.05.023_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104160","article-title":"Preventing olanzapine-induced weight gain using betahistine: a study in a rat model with chronic olanzapine treatment","volume":"9","author":"Lian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.05.023_b0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0896-6273(01)00433-0","article-title":"A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala","volume":"31","author":"Lin","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2019.05.023_b0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbr.2016.10.011","article-title":"Psychotomimetic effects of different doses of MK-801 and the underlying mechanisms in a selective memory impairment model","volume":"320","author":"Liu","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0180","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fnbeh.2017.00260","article-title":"Olanzapine reverses MK-801-induced cognitive deficits and region-specific alterations of NMDA receptor subunits","volume":"11","author":"Liu","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2019.05.023_b0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.pbb.2012.12.002","article-title":"Chronic olanzapine administration in rats: effect of route of administration on weight, food intake and body composition","volume":"103","author":"Mann","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2019.05.023_b0190","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin \u2013 a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in Alzheimer's Disease Guest Editor: Davide Brambilla","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0195","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.brainres.2019.05.023_b0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-0173(99)00044-2","article-title":"Glutamate receptor expression in schizophrenic brain","volume":"31","author":"Meador-Woodruff","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.brainres.2019.05.023_b0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1196\/annals.1300.005","article-title":"Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia","volume":"1003","author":"Meador-Woodruff","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2019.05.023_b0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11011-017-0132-z","article-title":"Evaluation of metformin effects in the chronic phase of spontaneous seizures in pilocarpine model of temporal lobe epilepsy","volume":"33","author":"Mehrabi","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2019.05.023_b0215","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2018.12.032","article-title":"Effects of tipepidine on MK-801-induced cognitive impairment in mice","volume":"1710","author":"Miki","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tics.2011.11.017","article-title":"Developing treatments for impaired cognition in schizophrenia","volume":"16","author":"Minzenberg","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.brainres.2019.05.023_b0225","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0230","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0092-8674(00)81972-8","article-title":"Mice with reduced NMDA receptor expression display behaviors related to schizophrenia","volume":"98","author":"Mohn","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2019.05.023_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.brainres.2019.05.023_b0240","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.biopsych.2006.07.025","article-title":"A genetic variant of the serine racemase gene is associated with schizophrenia","volume":"61","author":"Morita","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0245","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.numecd.2017.04.009","article-title":"Metformin effects on the heart and the cardiovascular system: a review of experimental and clinical data","volume":"27","author":"Nesti","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.brainres.2019.05.023_b0250","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.764","article-title":"Effects of haloperidol, olanzapine, ziprasidone, and PHA-543613 on spatial learning and memory in the Morris water maze test in naive and MK-801-treated mice","volume":"7","author":"Ning","year":"2017","journal-title":"Brain Behav."},{"key":"10.1016\/j.brainres.2019.05.023_b0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025932","article-title":"Metformin: a hopeful promise in aging research","volume":"6","author":"Novelle","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.brainres.2019.05.023_b0260","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/0269881116672098","article-title":"Swertisin ameliorates pre-pulse inhibition deficits and cognitive impairment induced by MK-801 in mice","volume":"31","author":"Oh","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.brainres.2019.05.023_b0265","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.psc.2017.08.005","article-title":"The effect of cognitive behavioral interventions on depression and anxiety symptoms in patients with schizophrenia spectrum disorders: a systematic review","volume":"40","author":"Opoka","year":"2017","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.brainres.2019.05.023_b0270","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2019.05.023_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2014.06.025","article-title":"Oleanolic acid attenuates MK-801-induced schizophrenia-like behaviors in mice","volume":"86","author":"Park","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2019.05.023_b0280","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic acid in schizophrenia: a systematic review and meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.brainres.2019.05.023_b0285","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JOE-15-0074","article-title":"Metformin attenuates olanzapine-induced hepatic, but not peripheral insulin resistance","volume":"227","author":"Remington","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.brainres.2019.05.023_b0290","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s11011-015-9677-x","article-title":"Metformin improves anxiety-like behaviors through AMPK-dependent regulation of autophagy following transient forebrain ischemia","volume":"30","author":"Sarkaki","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.brainres.2019.05.023_b0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.brainres.2019.05.023_b0300","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.05.023_b0305","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.05.023_b0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1017\/S1461145706006869","article-title":"The effects of repeated administrations of MK-801 on ERK and GSK-3beta signalling pathways in the rat frontal cortex","volume":"10","author":"Seo","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.brainres.2019.05.023_b0315","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","article-title":"Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies","volume":"60","author":"Sullivan","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0320","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainresbull.2018.04.008","article-title":"Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-kappaB and MAPK signaling pathway","volume":"140","author":"Tao","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2019.05.023_b0325","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s40263-015-0282-7","article-title":"Anxiety in patients with schizophrenia: epidemiology and management","volume":"29","author":"Temmingh","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainres.2019.05.023_b0330","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2018.00042","article-title":"Chronic MK-801 application in adolescence and early adulthood: a spatial working memory deficit in adult long-evans rats but no changes in the hippocampal NMDA receptor subunits","volume":"9","author":"Uttl","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2019.05.023_b0335","doi-asserted-by":"crossref","DOI":"10.1126\/stke.2001.100.re12","article-title":"Judging a protein by more than its name: GSK-3","author":"Woodgett","year":"2001","journal-title":"Sci. STKE"},{"key":"10.1016\/j.brainres.2019.05.023_b0340","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1176\/appi.ajp.2007.07010079","article-title":"Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study","volume":"165","author":"Wu","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0345","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2007.56-b","article-title":"Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial","volume":"299","author":"Wu","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.brainres.2019.05.023_b0350","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/mp.2015.221","article-title":"Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials","volume":"21","author":"Wu","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0355","article-title":"Combination of metformin and lifestyle intervention for antipsychotic-related weight gain: a meta-analysis of randomized controlled trials","author":"Zheng","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.brainres.2019.05.023_b0360","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuroscience.2014.01.021","article-title":"Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of Granulocyte-Macrophage Colony-Stimulating Factor in adult rats","volume":"266","author":"Zhu","year":"2014","journal-title":"Neuroscience"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319302781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899319302781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T09:06:54Z","timestamp":1663492014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899319302781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":72,"alternative-id":["S0006899319302781"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.05.023","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}